Non-Invasive Prenatal Testing Market Outlook, Development, Applications, Verticals and Strategies.

Read Time:3 Minute, 20 Second

In this report, Lead Analyst discusses the Non-Invasive Prenatal Testing market in terms of its Market Outlook, Development, Applications, Verticals and Strategies.

 

Introduction

Non-Invasive Prenatal Testing (NIPT) is a new way to detect fetal chromosomal abnormalities, it utilizes blood samples from the mother.
The test analyzes for levels of fetal DNA in the maternal blood and can be used to diagnose Down syndrome, Edwards syndrome, Patau syndrome, Turner’s syndrome, and sex chromosome disorders. Non-Invasive Prenatal Testing Market is expected to grow at a CAGR of xx% from 2019-2025. The market is fragmented and companies are constantly focusing on new technologies to offer better testing solutions. Non-Invasive Prenatal Testing Market is broadly divided into three segments: Diagnostic, Products, and Services.

 

Click on the below tab to avail the Sample copy of the report

Request For Sample

 

Non-Invasive Prenatal Testing Market Timeline

The Non-Invasive Prenatal Testing market is expected to reach USD 13.02 Billion by 2024, at a CAGR of 8.81% during the forecast period from 2017 to 2024. In 1994, the US FDA approved the use of non-invasive prenatal testing to detect Down’s syndrome. In 2009, the number of mothers using this method has increased more than tenfold. The growth in the market has been fueled by the increasing cases of Down’s syndrome, a decrease in maternal and fetal mortality rate, and availability of cost-effective technology.

 

Non-Invasive Prenatal Testing Market Overview

Non-invasive prenatal testing is a technique to test for fetal abnormalities such as Down syndrome and fetal DNA testing. There are many factors that are involved in the growth of this market, such as the rise in fertility rates and the restrictions imposed by some countries on invasive prenatal testing.

 

Types of tests used for prenatal testing

MPNST or amniocentesis is the most common prenatal test used. Physicians use this test to determine the risk of genetic disorders and other birth defects in a fetus. It is also used to identify chromosomal abnormalities that can cause miscarriage and even death. Additionally, it aids in determining certain birth defects such as Down syndrome, Turner syndrome, and Patau syndrome.

 

Types of tests being developed for prenatal testing

Diapering: A diaper that is made from a type of cloth (clothing) intended to cover the genitals during activities such as sports, swimming, or overnight use. They are available in both disposable and cloth formulations.

 

Developments in Prenatal Testing

The number of prenatal tests being used during pregnancy has seen a significant growth in the recent past. This is owing to the increasing risks associated with pregnancy and the advancement in recent years in DNA sequencing technologies, which has made it easier to identify the baby’s sex and other important details. The non-invasive prenatal testing market is expected to grow at a CAGR of 3.1% from 2016 to 2020.

 

Click on the below tab for Instant Purchase of the report with flat $500 discount

Request For Instant Purchase

 

The pregnancy process with the use of non invasive prenatal testing

Non-invasive prenatal testing (NIPT) is a non-invasive and cost-effective method of identifying fetal chromosomal abnormalities. The technology replaced amniocentesis which has been known to cause miscarriage in as many as 1% of cases. NIPT is gaining more and more attention due to its low costs, efficiency, accuracy, and the fact that it does not pose any risks to the fetus or mother.

 

Conclusion

The Non-Invasive Prenatal testing market is expected to grow at a CAGR of $22.11 from 2016–2020. The market for Non-Invasive Prenatal testing will be driven by increasing prevalence of prenatal diagnosis, rising concern over the accuracy of traditional invasive tests as well as the growing number of women who are aware about their pregnancy and care for themselves and their unborn child. Moreover, improved availability of non-invasive tests is likely to increase the adoption ratio in the future.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post What One Thing Do You Need To Know In The Digestible Sensors Market?
Next post Leukaphereis has a market size share of 51% and their revenue per annum is $2.8 million